Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, et al. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis. Pediatr Crit Care Med. 2019;20(7):e342-e351.

Randall EC, Zadra G, Chetta P, Lopez BG, Syamala S, Basu SS, et al. Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging. Mol Cancer Res. 2019;17(5):1155-1165.

Maleki Z, Baloch Z, Lu R, Shafique K, Song SJ, Viswanathan K, et al. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study. Cancer Cytopathol. 2019;127(5):306-315.

Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, et al. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. Nat Commun. 2019;10(1):4358.

Westblade LF, Satlin MJ, Albakry S, Botticelli B, Robertson A, Alston T, et al. Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients. Transpl Infect Dis. 2019;21(6):e13167.

Kuchay S, Wang H, Marzio A, Jain K, Homer H, Fehrenbacher N, et al. GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase. Nat Struct Mol Biol. 2019;26(7):628-636.

Canver MC, Tekle T, Compton ST, Callan K, Burd EM, Zimmer BL, et al. Performance of Five Commercial Identification Platforms for Identification of Staphylococcus delphini. J Clin Microbiol. 2019;57(11).

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, et al. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clin Cancer Res. 2019;25(1):43-51.

Nouizi F, Kwong TC, Ruiz J, Cho J, Chan Y-, Ikemura K, et al. A thermo-sensitive fluorescent agent based method for excitation light leakage rejection for fluorescence molecular tomography. Phys Med Biol. 2019;64(3):035007.

Stopsack KH, Whittaker CA, Gerke TA, Loda M, Kantoff PW, Mucci LA, et al. Aneuploidy drives lethal progression in prostate cancer. Proc Natl Acad Sci U S A. 2019;116(23):11390-11395.